Company Data
BioAtla Inc.
Ticker
BCAB
Current Price
$1.735 -44.75%
Market Cap
$2.9M
Price Target
Refer to Report
Volume
1.0M
52wk Range
$2.81 - $71.5
Overview
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs.